![](https://newsheater.com/wp-content/uploads/2020/01/Image-136.png)
Revolution Medicines Inc (RVMD): A Technical Analysis
RVMD has 36-month beta value of 1.44. Analysts have mixed views on the stock, with 7 analysts rating it as a “buy,” 8 as “overweight,”
RVMD has 36-month beta value of 1.44. Analysts have mixed views on the stock, with 7 analysts rating it as a “buy,” 8 as “overweight,”
The stock of Revolution Medicines Inc (RVMD) has seen a 4.66% increase in the past week, with a -4.72% drop in the past month, and
Revolution Medicines Inc (NASDAQ: RVMD) has seen a rise in its stock price by 2.21 in relation to its previous close of 42.58. However, the
The stock of Revolution Medicines Inc (RVMD) has seen a -7.27% decrease in the past week, with a -1.13% drop in the past month, and
The 36-month beta value for RVMD is at 1.42. Analysts have varying views on the stock, with 6 analysts rating it as a “buy,” 7
Revolution Medicines Inc (NASDAQ: RVMD) has experienced a decline in its stock price by -2.44 compared to its previous closing price of 47.94. benzinga.com reported
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.